Volume Spike Investor

Biosante Pharmaceuticals, Inc. (NASDAQ: BPAX) is up after announcing that development of its GVAX Prostate Cancer Vaccine has been reinitiated. The company said that manufacturing of the new GVAX Prostate is in process and that regulatory steps to lift the GVAX Prostate clinical hold prior to trial initiation are being taken.  Further noted was that [...]

American International Group, Inc. (NYSE: AIG) is going for a DAY THREE…. Shares are up 5% at $38.18 and we have already seen 1 million shares as of 8:33 AM EST. BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) is up almost 17% at $2.00 on just over 1 million shares as of 8:27 AM EST.  The company [...]

These are this Monday’s top day trader and active trader alert stocks seen in the pre-market hours.  It is surprising on the lack of stocks with double-digit gainers or losers.  A brief explanation and volume comparisons are provided where applicable. Smith (SII) is up again and up far more than what options were indicating on [...]

BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) is one of this mornings top gainers after it reported positive safety data in its ongoing LibiGel Phase III clinical development program.  The unblinded data have been reviewed by the independent DMC of the LibiGel Cardiovascular and Breast Cancer Safety Study and the DMC unanimously recommended continuation of the study [...]

BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) is up big this morning on a presentation of H1N1 vaccine results at the Immunotherapeutics & Vaccine Summit in Providence, RI. Its BioVant increased the protective effect of vaccines for multiple flu strains, including a potential new vaccine against H1N1 or swine flu.  The company noted that it resulted in [...]

BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) is up big after announcing positive safety data in its ongoing LibiGel Phase III study and it plans to continue studies and submit an FDA new drug application by mid-2011. At 8:48 AM EST we have shares up 37% at $2.45, still down over 50% from a 52-week high of [...]